However, the initial suppression of ovarian function and thereby suppressing progesterone levels may prevent upregulation of the RANK/RANKL pathway, rendering tumor cells of especially the basal type more vulnerable to undergoing apoptosis after being exposed to chemotherapy. Here, TNFRSF11A is linked to neoplasm.